The effect of menopausal hormone therapy on breast atrophy in post-menopausal women

Elizabeth M Kurian, Elena Lavrovskaya, Jennifer Blankenship, I. Tien Yeh

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Normal breast physiology in women shows breast density is inversely related to age. Few tissue-based studies examine the influence of menopausal hormone therapy on benign breast epithelial proliferation. Increased breast proliferation may be associated with an increased risk of subsequent carcinoma of the breast. We examined 105 archival breast biopsies from postmenopausal patients, including 53 patients without hormone therapy and 52 patients with hormone therapy. Atrophy in the breast was recorded. Partial atrophic or non-atrophic biopsies were further evaluated for fibrocystic changes, and divided into non-proliferative and proliferative subgroups. Estrogen receptor (ER) and progesterone receptor (PR) expressions were scored semi-quantitatively by immunohistochemistry. Complete atrophy was more common in postmenopausal patients without hormone therapy in comparison to patients with hormone therapy. The ER and PR expression appeared increased in association with breast proliferation, but were not statistically significant between the groups of patients with regard to hormone therapy.

Original languageEnglish (US)
Title of host publicationAdvances in Medicine and Biology
PublisherNova Science Publishers, Inc.
Pages123-133
Number of pages11
Volume17
ISBN (Electronic)9781612094939
ISBN (Print)9781611227901
StatePublished - Jan 1 2011
Externally publishedYes

Fingerprint

Atrophy
Breast
Hormones
Progesterone Receptors
Estrogen Receptors
Therapeutics
Biopsy
Immunohistochemistry
Breast Neoplasms

Keywords

  • breast epithelium
  • Estrogen receptor
  • HT
  • MHT
  • Postmenopausal women
  • Progesterone receptor

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Kurian, E. M., Lavrovskaya, E., Blankenship, J., & Yeh, I. T. (2011). The effect of menopausal hormone therapy on breast atrophy in post-menopausal women. In Advances in Medicine and Biology (Vol. 17, pp. 123-133). Nova Science Publishers, Inc..

The effect of menopausal hormone therapy on breast atrophy in post-menopausal women. / Kurian, Elizabeth M; Lavrovskaya, Elena; Blankenship, Jennifer; Yeh, I. Tien.

Advances in Medicine and Biology. Vol. 17 Nova Science Publishers, Inc., 2011. p. 123-133.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kurian, EM, Lavrovskaya, E, Blankenship, J & Yeh, IT 2011, The effect of menopausal hormone therapy on breast atrophy in post-menopausal women. in Advances in Medicine and Biology. vol. 17, Nova Science Publishers, Inc., pp. 123-133.
Kurian EM, Lavrovskaya E, Blankenship J, Yeh IT. The effect of menopausal hormone therapy on breast atrophy in post-menopausal women. In Advances in Medicine and Biology. Vol. 17. Nova Science Publishers, Inc. 2011. p. 123-133
Kurian, Elizabeth M ; Lavrovskaya, Elena ; Blankenship, Jennifer ; Yeh, I. Tien. / The effect of menopausal hormone therapy on breast atrophy in post-menopausal women. Advances in Medicine and Biology. Vol. 17 Nova Science Publishers, Inc., 2011. pp. 123-133
@inbook{a18e7d0643e745349a14fa75a6e18d4f,
title = "The effect of menopausal hormone therapy on breast atrophy in post-menopausal women",
abstract = "Normal breast physiology in women shows breast density is inversely related to age. Few tissue-based studies examine the influence of menopausal hormone therapy on benign breast epithelial proliferation. Increased breast proliferation may be associated with an increased risk of subsequent carcinoma of the breast. We examined 105 archival breast biopsies from postmenopausal patients, including 53 patients without hormone therapy and 52 patients with hormone therapy. Atrophy in the breast was recorded. Partial atrophic or non-atrophic biopsies were further evaluated for fibrocystic changes, and divided into non-proliferative and proliferative subgroups. Estrogen receptor (ER) and progesterone receptor (PR) expressions were scored semi-quantitatively by immunohistochemistry. Complete atrophy was more common in postmenopausal patients without hormone therapy in comparison to patients with hormone therapy. The ER and PR expression appeared increased in association with breast proliferation, but were not statistically significant between the groups of patients with regard to hormone therapy.",
keywords = "breast epithelium, Estrogen receptor, HT, MHT, Postmenopausal women, Progesterone receptor",
author = "Kurian, {Elizabeth M} and Elena Lavrovskaya and Jennifer Blankenship and Yeh, {I. Tien}",
year = "2011",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781611227901",
volume = "17",
pages = "123--133",
booktitle = "Advances in Medicine and Biology",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - The effect of menopausal hormone therapy on breast atrophy in post-menopausal women

AU - Kurian, Elizabeth M

AU - Lavrovskaya, Elena

AU - Blankenship, Jennifer

AU - Yeh, I. Tien

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Normal breast physiology in women shows breast density is inversely related to age. Few tissue-based studies examine the influence of menopausal hormone therapy on benign breast epithelial proliferation. Increased breast proliferation may be associated with an increased risk of subsequent carcinoma of the breast. We examined 105 archival breast biopsies from postmenopausal patients, including 53 patients without hormone therapy and 52 patients with hormone therapy. Atrophy in the breast was recorded. Partial atrophic or non-atrophic biopsies were further evaluated for fibrocystic changes, and divided into non-proliferative and proliferative subgroups. Estrogen receptor (ER) and progesterone receptor (PR) expressions were scored semi-quantitatively by immunohistochemistry. Complete atrophy was more common in postmenopausal patients without hormone therapy in comparison to patients with hormone therapy. The ER and PR expression appeared increased in association with breast proliferation, but were not statistically significant between the groups of patients with regard to hormone therapy.

AB - Normal breast physiology in women shows breast density is inversely related to age. Few tissue-based studies examine the influence of menopausal hormone therapy on benign breast epithelial proliferation. Increased breast proliferation may be associated with an increased risk of subsequent carcinoma of the breast. We examined 105 archival breast biopsies from postmenopausal patients, including 53 patients without hormone therapy and 52 patients with hormone therapy. Atrophy in the breast was recorded. Partial atrophic or non-atrophic biopsies were further evaluated for fibrocystic changes, and divided into non-proliferative and proliferative subgroups. Estrogen receptor (ER) and progesterone receptor (PR) expressions were scored semi-quantitatively by immunohistochemistry. Complete atrophy was more common in postmenopausal patients without hormone therapy in comparison to patients with hormone therapy. The ER and PR expression appeared increased in association with breast proliferation, but were not statistically significant between the groups of patients with regard to hormone therapy.

KW - breast epithelium

KW - Estrogen receptor

KW - HT

KW - MHT

KW - Postmenopausal women

KW - Progesterone receptor

UR - http://www.scopus.com/inward/record.url?scp=85060168519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060168519&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85060168519

SN - 9781611227901

VL - 17

SP - 123

EP - 133

BT - Advances in Medicine and Biology

PB - Nova Science Publishers, Inc.

ER -